医药巨头联手区块链，聪明钱早已抢跑

Group 1 - Han Yu Pharmaceutical announced a strategic partnership with KuCoin to advance the first pilot project in mainland China for RWA tokenization based on "future revenue rights of innovative drug research and development" [2] - The combination of pharmaceuticals and blockchain has created significant market interest, but there are concerns about the "running ahead" phenomenon unique to the A-share market [2][3] - Historical observations indicate that seemingly sudden positive news often has prior indications in trading data, suggesting that institutional funds may have already positioned themselves before the announcement [2] Group 2 - The A-share market tends to "buy expectations" rather than "buy facts," leading to a situation where good news often serves as an opportunity for smart money to realize profits [3] - Examples from the stablecoin concept show that while the Shanghai Composite Index rose nearly 500 points from April to July 2025, individual stocks within the digital currency theme exhibited vastly different performances, indicating selective institutional positioning [3][5] - The trading behavior of stocks like "Cuiwei Co." shows that institutional activity can be detected before a market trend becomes apparent, highlighting the advantage of professional investors who utilize quantitative tools to capture fund movements [5] Group 3 - The trading data of "Dongsoft Group" reveals a lack of institutional activity initially, with only brief participation later, explaining the stark performance differences among stocks in the same sector [6][8] - "Runhe Software" initially showed active institutional participation but lacked sustainability, leading to weak stock performance, while "Zhongke Jiangnan" gained momentum after the index surpassed 3600 points [10][12] - The analysis of trading data emphasizes the importance of understanding whether institutional funds have already entered the market before news releases, as this is crucial for investment success [13]